Skip to main content
Smart Investors Daily
ML

NASDAQ · MLAB

Mesa Laboratories, Inc.

Technology · Hardware, Equipment & Parts

$124.76

Up+$5.61 (+4.71%)

Updated Aug 22, 2026, 4:20 AM

SID Score

6.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
431.9M
P/E ratio
-689.38
Dividend yield
0.51%
52-week range
$71.07 – $121.90
Volume
160.69K
Avg. volume
155.9K

Price performance

MLAB price history

1M range · 21 trading sessions · Daily adjusted prices

MLAB closed at $124.76 after 21 trading sessions, up 27.96% for the selected period.

Last close
$124.76
Period change
+27.96%
Period low
$97.50
Period high
$124.76
Daily close
View OHLC price history
MLAB OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 21, 2026$119.94$124.89$119.03$124.76160.69K
Aug 20, 2026$118.47$121.90$118.47$119.15185.39K
Aug 19, 2026$109.91$120.45$108.85$119.72236.47K
Aug 18, 2026$106.66$109.35$105.065$107.94194.22K
Aug 17, 2026$105.05$110.96$103.94$107.64139.57K
Aug 14, 2026$113.09$115.43$105.24$106.04161.03K
Aug 13, 2026$112.21$115.52$110.215$113.20254.29K
Aug 12, 2026$110.69$113.29$108.5801$112.80194.14K
Aug 11, 2026$98.12$111.39$93.03$111.23410.31K
Aug 10, 2026$101.42$103.615$100.5125$101.62103.05K
Aug 7, 2026$102.01$103.075$100.225$102.65103.03K
Aug 6, 2026$101.005$102.055$100.015$101.0185.14K
Aug 5, 2026$100.10$103.62$99.60$102.62103.34K
Aug 4, 2026$104.49$105.91$100.63$101.14167.44K
Aug 3, 2026$102.68$105.80$101.78$104.43138.31K
Jul 31, 2026$100.32$101.94$95.75$100.81141K
Jul 30, 2026$99.60$101.10$98.6901$101.0490.86K
Jul 29, 2026$99.92$101.28$97.87$99.6695.43K
Jul 28, 2026$97.77$101.68$97.77$101.10112.56K
Jul 27, 2026$97.71$98.52$95.86$97.7792.26K
Jul 24, 2026$101.50$102.52$96.43$97.50120.89K

Latest MLAB news

The latest Smart Investors Daily articles mentioning MLAB.

MLAB research

Overview

Company profile and research snapshot.

Company profile

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$120.00
Implied upside
Analysts
MLAB recent ratings
DateFirmRatingTarget
Aug 14, 2026Wells FargoEqual-Weight
Feb 4, 2026Wells FargoEqual-Weight
Dec 15, 2025Wells FargoEqual-Weight
Aug 8, 2025Wells FargoEqual-Weight
May 30, 2025Wells FargoUnderweight
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.